Korea Investment Corp’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-31,600
Closed -$357K 761
2022
Q2
$357K Sell
31,600
-22,700
-42% -$272K ﹤0.01% 742
2022
Q1
$882K Buy
54,300
+22,300
+70% +$571K ﹤0.01% 706
2021
Q4
$1.52M Sell
32,000
-1,400
-4% -$84K ﹤0.01% 674
2021
Q3
$2.42M Buy
33,400
+200
+0.6% +$14.5K 0.01% 644
2021
Q2
$2.79M Buy
+33,200
New +$2.19M 0.01% 643

Other funds holding NBP

Korea Investment Corp's NBP Position: Q3 2022 in Review

Korea Investment Corp sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 31,600 shares — an estimated $357K sold.

Korea Investment Corp first reported a position in NBP in Q2 2021 and held it in 5 quarters. The position peaked at $2.79M in Q2 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Korea Investment Corp reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Korea Investment Corp sold 31,600 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $357K.
  • Korea Investment Corp first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 5 quarters.
  • Korea Investment Corp's NovaBridge Biosciences American Depositary Shares position peaked at $2.79M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Korea Investment Corp's 13F filing for Q3 2022, filed 10 Nov 2022.